Time to Nail Down Some Profits on Nordson

 | Apr 11, 2017 | 9:07 AM EDT
  • Comment
  • Print Print
  • Print
Stock quotes in this article:


Sleepy industrial machinery company Nordson (NDSN) has been a great investment for individuals who may have been buyers in early 2016 around $55; but we need to be forward looking when it comes to investing. Let's check the latest charts and indicators to see what could happen in the next few weeks:

In this daily chart of NDSN, above, we can see that the rising 50-day moving average line has been a pretty good indicator of the uptrend on NDSN. Prices are still above the rising 50-day moving average line, but recent tests of that line suggest we could break it soon.

The On-Balance-Volume (OBV) line rose from May to February confirming the rally, but the line has turned lower since early March. A declining OBV line suggests that sellers of NDSN have become more aggressive, with heavier trading volume on days when the stock has closed lower.

In the bottom panel, the Moving Average Convergence Divergence (MACD) oscillator has been in a take-profits mode since mid-March and could soon cross below the zero line for an outright sell signal.

In this weekly chart of NDSN, above, we can see that prices are above the rising 40-week moving average line. The weekly OBV line was neutral until June 2016 and then it turned bullish. The MACD oscillator has been above the zero line since early 2016, but it has recently signaled a take-profits sell.

Bottom line: when you own a stock that has more than doubled, there is a reluctance to take profits. We hope it is going to go still higher, but hope is not an investment strategy. NDSN looks like it will correct to the downside - maybe back to $115 or $110 or even $105 where the 200-day moving average intersects. This might be a good time to nail down some profits.

Columnist Conversations

today is a good day to lighten the load and take some positions off the table. SOLD WB OCT 85 CALL AT 11 (i...
I reached out last week to my close friend Ken Shreve, who is a prominent writer for the IBD.  I asked Ke...
I reached out last week to my close friend Ken Shreve, who is a prominent writer for the IBD.  I asked Ke...
View Chart »  View in New Window »



News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.